Technical Data
Clenbuterol belongs to the group of agonists. In livestock production clenbuterol improves the meat/fat ratio in fattened animals or accelerate the growth. Up to now agonists have not been authorized as adjuvants for fattening. In addition to its lipolytic and anabolic effect, clenbuterol has a relaxing effect on non-striated musculature on which is based its therapeutic use as an antiasthmatic and a tocolytic agent. When employed as a fattening adjuvant, as compared with the therapeutic use, clenbuterol is administered in a 5 to 10 times higher dose. Therefore, it is possible that clenbuterol residues may lead to a risk for consumers after illegal administration. Using the clenbuterol monoclonal antibody, it is possible to detect clenbuterol and other agonists in urine, muscle and liver both rapidly and with accuracy.

Suitable for use in ELISA, Western Blot and Immunohistochemistry. Other applications not tested.

Recommended Dilution:
Optimal dilutions to be determined by the researcher.

Storage and Stability:
May be stored at 4C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20C. Aliquots are stable for at least 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
100ul-20CBlue IceSheep
Not determined
Purified by ammonium sulfate precipitation.
Supplied as a liquid in 20mM phosphate, pH 7.2, 150mM sodium chloride, 0.09% sodium azide.
Recognizes Clenbuterol (100%). Crossreactivity: Mabuterol: 114%; Brombuterol: 96%; Methyl-Clenbuterol: 53%; Mapenterol: 49%; Salbutamol: 3.8%; Terbutaline: 1.6%; Cimaterol: <1.0%; Pirbuterol: 0.9%; Ractopamine: <0.2%; Feneterol: <0.2%.
Intended for research use only. Not for use in human, therapeutic, or diagnostic applications.
1. Smith, D.J., (1998), "The pharmacokinetics, metabolism and tissue residues of beta-adrenergic agonists in livestock", J. Anim. Sci., 76: 173-194.